Swiss group EMS-CHEMIE has announced the forthcoming bid on its compatriot AXANTIS (turnover CHF 477 million for the 1998-99 financing period), which produces cellulose, for the sum of CHF 570.2 million. EMS-CHEMIE, which already controls 24.73% of the capital, proposes CHF 330 per share.